Ocugen OCGN
NASDAQ OCGN
$1.09 +0.06 (+5.83%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ocugen (OCGN) Share-based Compensation (IS) (2022 - 2023)

Updated

Ocugen's Share-based Compensation (IS) came in at $2.17 million for Q3 2023, down 12.9% from $2.5 million a year earlier.

Analysis

Ocugen (OCGN) Share-based Compensation (IS) (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Ocugen 349.22 Mn 165.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2.17 Mn
Sep 30, 2022 2.50 Mn
API Access

Ocugen Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=OCGN&period=max&api_key=YOUR_API_KEY